Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Blastic plasmacytoid dendritic cell neoplasm

Blastic plasmacytoid dendritic cell neoplasm

Part of Leukemia

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Blastic plasmacytoid dendritic cell neoplasm

2 trials tracked for Blastic plasmacytoid dendritic cell neoplasm.

2Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 2
  1. Phase 2 Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD Completed
  2. Phase 2 DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Triple consolidation with CAR T cells yields sustained remission in relapsed BPDCN
Allergy & Immunology Sys. Review
Triple consolidation with CAR T cells yields sustained remission in relapsed BPDCN New treatment strategy shows promise for rare blood cancer
This case report and literature review describes a 55-year-old man with relapsed/refractory BPDCN and CNS involvement who achieved sustained…
A new three-part treatment plan helped a man with a rare, aggressive blood cancer achieve long-term remission when no donor was available.
Frontiers Jul 31, 2026
Pivekimab sunirine shows activity in frontline and relapsed Blastic plasmacytoid dendritic cell neoplasm
Dermatology Phase I
Pivekimab sunirine shows activity in frontline and relapsed Blastic plasmacytoid dendritic cell neoplasm A New Drug Shows Striking Promise for a Rare and Aggressive Blood Cancer
This phase I/II single-arm trial evaluated pivekimab sunirine in adults with Blastic plasmacytoid dendritic cell neoplasm (BPDCN).
For a cancer with very few options, this therapy is changing the outlook for patients and creating a clear path to potentially curative stem…
Apr 9, 2026